Neurochemical and behavioral characterization of potential antidepressant properties of indeloxazine hydrochloride

Neuropharmacology

Volumn 37, Issue 9, 1998, Pages 1169-1176

  Yamaguchi, T ^a   Ohyama, M ^a   Suzuki, M ^a   Ozawa, Y ^a   Hatanaka, K ^a   Hidaka, K ^a   Yamamoto, M ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

5 HT; Amitriptyline; Antidepressant; Indeloxazine; Norepinephrine

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; INDELOXAZINE; NISOXETINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN MEMBRANE; BRAIN SYNAPTOSOME; CEREBELLUM CORTEX; CONTROLLED STUDY; DEPRESSION; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; FORCED SWIMMING TEST; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; MOUSE; MOUSE KILLING BEHAVIOR; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; BRAIN; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED ICR; MORPHOLINES; MOTOR ACTIVITY; NOREPINEPHRINE; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; SEROTONIN; SYNAPTOSOMES;

EID: 0032428889     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00009-4     Document Type: Article

References (29)

1. 3H] GBR12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J. Neurochem. 48, 1887-1896.
2. Blier, P., de Montigny, C., 1994. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226.
3. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology 35, 63-70.
4. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
5. Cooper, F., Leonard, B.E., Schnieden, H., 1972. The role of catecholamines in the reversal of reserpine-induced hypothermia in mice by desipramine and chlorpromazine. Br. J. Pharmacol. 46, 561-562.
6. 3H]imipramine. J. Pharmacol. Exp. Ther. 242, 364-371.
7. Fuller, R.W., 1994. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55, 163-167.
8. Harada, M., Maeno, H., 1979. Biochemical characteristics of a potential antidepressant, 2-(7-indenyloxymethy)morpholine hydrochloride (YM-08054-1). Biochem. Pharmacol. 28, 2645-2651.
9. Kano, T., Katayama, Y., Miyazaki, S., Kinoshita, K., Kawamata, T., Tsubokawa, T., 1993. Effects of indeloxazine on hippocampal CA1 pyramidal cell damage following transient cerebral ischemia in the gerbil. Neuropharmacology 32, 307-310.
10. Kihara, T., Ikeda, M., 1995. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. J. Pharmacol. Exp. Ther. 272, 177-183.
11. Leonard, B.E., 1995. Mechanisms of action of antidepressants. CNS Drugs 4 (Suppl. 1), 1-12.
12. Montgomery, S.A., 1995. Rapid onset of action of venlafaxine. Int. Clin. Psychopharmacol. 10 (Suppl. 2), 21-27.
13. Nelson, J.C., Mazure, C.M., Bowers, M.B., Jatlow, P.I., 1991. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch. Gen. Psychiatry 48, 303-307.
14. Nomura, S., Shimizu, J., Kinjo, M., Kametani, H., Nakazawa, T., 1982. A new behavioral test for antidepressant drugs. Eur. J. Pharmacol. 83, 171-175.
15. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, New York.
16. Perrault, G., Morel, E., Zivkovic, B., Sanger, D.J., 1992. Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharmacol. Biochem. Behav. 42, 45-47.
17. Ruch-Monachon, M.A., Jalfre, M., Haefely, W., 1976. Drugs and PGO waves in the lateral geniculate body of the curarized cat. II. PGO wave activity and brain 5-hydroxytryptamine. Arch. Int. Pharmacodyn. 219, 269-286.
18. Seth, R., Jennings, A.L., Bindman, J., Bergmann, K., 1992. Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. Br. J. Psychiatry. 161, 562-565.
19. Shimizu-Sasamata, M., Yamamoto, M., Okada, M., Yamaguchi, T., Tamura, A., 1991. Effects of indeloxazine hydrochloride on behavioral and biochemical changes in the chronic phase of focal cerebral ischemia in rats. Arch. Int. Pharmacodyn. 314, 74-89.
20. Tachikawa, S., Harada, M., Maeno, H., 1979. Pharmacological and biochemical studies on a new compound, 2-(7-indenyloxymethy)morpholine hydrochloride (YM-08054-1), and its derivatives with potential antidepressant properties. Arch. Int. Pharmacodyn. 238, 81-95.
21. Takeda, T., Hosokawa, M., Takeshita, S., Irino, M., Higuchi, K., Matsushita, M., Tomita, Y., Yasuhira, K., Hamamoto, H., Shimizu, K., Ishii, M., Yamamuro, T., 1981. A new murine model of accelerated senescence. Mech. Ageing Dev. 17, 183-194.
22. Tollefson, G.D., Tompson, R.G., Heiligenstein, J.H., James, S., Wong, D.T., Faries, D.E., Hyslop, D.L., 1993. Is the potent, dual uptake inhibition of norepinephrine and serotonin by LY248686 (duloxetine) associated with a more rapid and robust antidepressant response? Am. Coll. Neuropsychopharmacol. 32, 23.
23. Yamaguchi, T., Harada, M., Nagano, H., 1985. Effects of indeloxazine hydrochloride (YM-08054) on monoamines and their metabolites in rat brain. Biogenic Amines 3, 21-32.
24. Yamaguchi, T., Ozawa, Y., Suzuki, M., Yamamoto, M., Nakamura, T., Yamaura, A., 1996. Indeloxazine hydrochloride improves impairment of passive avoidance performance after fluid percussion brain injury in rats. Neuropharmacology 35, 329-336.
25. Yamamoto, M., 1990. Pharmacological and biochemical properties of indeloxazine hydrochloride, a new cerebral activator. Brain Dysfunct. 3, 130-147.
26. Yamamoto, M., Ooyama, M., Ozawa, Y., Okada, M., Tada, S., Yamaguchi, T., Endo, H., 1993. Effects of indeloxazine hydrochloride, a cerebral activator, on passive avoidance learning impaired by disruption of cholinergic transmission in rats. Neuropharmacology 32, 695-701.
27. Yamamoto, M., Shimizu, M., 1988. Electroencephalographic studies on a new cerebral activator, indeloxazine hydrochloride. Curr. Ther. Res. 43, 92-105.
28. Yamamoto, M., Takahashi, K., Yamaguchi, T., Takeuchi, H., Yatsugi, S., Kogure, K., 1992. Effects of indeloxazine hydrochloride, a new cerebral activator, on passive avoidance response in gerbils subjected to repeated cerebral ischemia by carotid artery occlusion. Res. Commun. Psychol. Psychiat. Behav. 17, 123-132.
29. Yamamoto, T., Ueki, S., 1978. Effects of drugs on hyperactivity and aggression induced by raphe lesions in rats. Pharmacol. Biochem. Behav. 9, 821-826.